Westlake BioPartners
Westlake BioPartners is a life science venture capital firm that focuses on investing in entrepreneurs to create companies that develop life-saving medicines. The firm is deeply integrated into the Los Angeles biotech community, providing personal attention, hands-on support, and connections to innovative resources. Westlake BioPartners is committed to empowering entrepreneurs and guiding them from ideation to clinical and commercial impact, with a focus on addressing the greatest unmet patient needs.
Westlake BioPartners
3075 Townsgate Road, Suite 140, Westlake Village, CA 91361
What We Do
Westlake BioPartners invests in entrepreneurs to create companies that develop life-saving medicines. They provide personal attention, hands-on support, and connections to innovative resources.
Portfolio
Capsida Biotherapeutics is developing targeted gene therapies for genetic disorders. They have received a $40 million license payment from AbbVie and are eligible for additional milestones and royalties.
#Biotechnology
Latigo Biotherapeutics focuses on developing non-opioid pain therapeutics. They closed a $150 million Series B financing led by Blue Owl Capital.
#Biotechnology
Arsenal Biosciences is a programmable cell therapy company focused on CAR T-cell therapies for solid tumors. They closed a $220 million Series B financing round.
#Biotechnology
ACELYRIN focuses on developing transformative medicines in immunology. They closed a $300 million Series C financing to accelerate Phase 3 development of izokibep.
#Biopharmaceuticals